Colin Lindsay MBChB, MRCP, PhD

Dr. Colin Lindsay was educated at Edinburgh University. He began Medical Oncology training at the Beatson West of Scotland Cancer Centre in 2006 and was awarded a four-year Medical Research Council Fellowship in 2009 to complete a PhD in the Cancer Research UK Beatson Institute. During this time, he was awarded the Association of Cancer Physicians McElwain Prize, an annual award offered to one UK medical oncology trainee for outstanding contribution to cancer research.

Upon completion of his PhD, Dr. Lindsay was closely involved with phase I of the Cancer Research UK Stratified Medicine Programme before being sponsored by the European Society for Medical Oncology and the International Association for the Study of Lung Cancer to undertake a translational lung cancer fellowship at Europe’s leading lung cancer center, the Gustave Roussy Institute in Villejuif, France. He returned to the UK and was appointed as a Clinical Senior Lecturer and Honorary Consultant in Medical Oncology at the Christie in 2017.

Dr. Lindsay is currently establishing translational research links in lung cancer in collaboration with Dr. Angeliki Malliri (CRUK Manchester Institute) and the Crick Institute in London. Along with his colleagues, he also organizes a clinical trials portfolio of more than 80 phases I-III trials and has been involved in practice-changing studies delivering promising new drugs and treatment regimens to patients. Dr. Lindsay’s overall objective is to implement new developments in lung cancer treatment, biomarkers, or genetic tests through effective clinical trial delivery.